BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 31635198)

  • 1. Enterovirus-Associated Hand-Foot and Mouth Disease and Neurological Complications in Japan and the Rest of the World.
    Gonzalez G; Carr MJ; Kobayashi M; Hanaoka N; Fujimoto T
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31635198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hand-Foot-and-Mouth Disease, Aseptic Meningitis, and Encephalitis Caused by Enterovirus].
    Fujimoto T
    Brain Nerve; 2018 Feb; 70(2):121-131. PubMed ID: 29433113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases.
    Mao Q; Wang Y; Bian L; Xu M; Liang Z
    Emerg Microbes Infect; 2016 Jul; 5(7):e75. PubMed ID: 27436364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical analysis of 555 outpatients with hand, foot and mouth diseases caused by different enteroviruses].
    Cui P; Li Y; Zhou CC; Zhou YH; Song CL; Qiu Q; Wang F; Guo C; Han SJ; Liang L; Yuan Y; Zeng MY; Yue J; Long L; Qin XH; Li Z; Chen XL; Zou YP; Cheng YB; Yu HJ
    Zhonghua Er Ke Za Zhi; 2019 Jun; 57(6):445-451. PubMed ID: 31216802
    [No Abstract]   [Full Text] [Related]  

  • 5. Hand, Foot, and Mouth Disease in China: Modeling Epidemic Dynamics of Enterovirus Serotypes and Implications for Vaccination.
    Takahashi S; Liao Q; Van Boeckel TP; Xing W; Sun J; Hsiao VY; Metcalf CJ; Chang Z; Liu F; Zhang J; Wu JT; Cowling BJ; Leung GM; Farrar JJ; van Doorn HR; Grenfell BT; Yu H
    PLoS Med; 2016 Feb; 13(2):e1001958. PubMed ID: 26882540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is a multivalent hand, foot, and mouth disease vaccine feasible?
    Klein M; Chong P
    Hum Vaccin Immunother; 2015; 11(11):2688-704. PubMed ID: 26009802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, etiological and epidemiological investigations of hand, foot and mouth disease in southern Vietnam during 2015 - 2018.
    Nhan LNT; Khanh TH; Hong NTT; Van HMT; Nhu LNT; Ny NTH; Nguyet LA; Thanh TT; Anh NT; Hang VTT; Qui PT; Viet HL; Tung TH; Ha DQ; Tuan HM; Thwaites G; Chau NVV; Thwaites L; Hung NT; van Doorn HR; Tan LV
    PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008544. PubMed ID: 32804980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The epidemiological characteristics of enterovirus infection before and after the use of enterovirus 71 inactivated vaccine in Kunming, China.
    Jiang H; Zhang Z; Rao Q; Wang X; Wang M; Du T; Tang J; Long S; Zhang J; Luo J; Pan Y; Chen J; Ma J; Liu X; Fan M; Zhang T; Sun Q
    Emerg Microbes Infect; 2021 Dec; 10(1):619-628. PubMed ID: 33682641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coxsackieviruses A6 and A16 associated with hand, foot, and mouth disease in Vietnam, 2008-2017: Essential information for rational vaccine design.
    Hoa-Tran TN; Dao ATH; Nguyen AT; Kataoka C; Takemura T; Pham CH; Vu HM; Hong TTT; Ha NTV; Duong TN; Thanh NTH; Shimizu H
    Vaccine; 2020 Dec; 38(52):8273-8285. PubMed ID: 33223308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance for severe hand, foot, and mouth disease from 2009 to 2015 in Jiangsu province: epidemiology, etiology, and disease burden.
    Ji H; Fan H; Lu PX; Zhang XF; Ai J; Shi C; Huo X; Bao CJ; Shan J; Jin Y
    BMC Infect Dis; 2019 Jan; 19(1):79. PubMed ID: 30669973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of single-step multiplex real-time RT-PCR assays for rapid diagnosis of enterovirus 71, coxsackievirus A6, and A16 in patients with hand, foot, and mouth disease.
    Puenpa J; Suwannakarn K; Chansaenroj J; Vongpunsawad S; Poovorawan Y
    J Virol Methods; 2017 Oct; 248():92-99. PubMed ID: 28662914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis on epidemiological characteristics of enterovirus 71 cases of hand-foot-mouth disease based on the active monitoring in Guangdong Province in 2011-2015].
    Xie DS; He JF; Yang F; Li H; Kang M; Zhang M; Ye X; Tan XH; Ni XH; Hu L; Sun LM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Jul; 52(7):738-742. PubMed ID: 29996302
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical characteristics of enterovirus A71 neurological disease during an outbreak in children in Colorado, USA, in 2018: an observational cohort study.
    Messacar K; Spence-Davizon E; Osborne C; Press C; Schreiner TL; Martin J; Messer R; Maloney J; Burakoff A; Barnes M; Rogers S; Lopez AS; Routh J; Gerber SI; Oberste MS; Nix WA; Abzug MJ; Tyler KL; Herlihy R; Dominguez SR
    Lancet Infect Dis; 2020 Feb; 20(2):230-239. PubMed ID: 31859216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The spatial-temporal distribution and etiological characteristics of hand-foot-and-mouth disease before and after EV‑A71 vaccination in Kunming, China, 2017-2020.
    Wang M; Chen T; Peng J; Luo Y; Du L; Lu Z; He J; Liu C; Gan Q; Ma W; Cun Z; Zheng Q; Chen W; Chen Y; Han M; Liu G; Li J
    Sci Rep; 2022 Oct; 12(1):17028. PubMed ID: 36220850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological and etiological characteristics of herpangina and hand foot mouth diseases in Jiangsu, China, 2013-2014.
    Yao X; Bian LL; Lu WW; Li JX; Mao QY; Wang YP; Gao F; Wu X; Ye Q; Li XL; Zhu FC; Liang Z
    Hum Vaccin Immunother; 2017 Apr; 13(4):823-830. PubMed ID: 27768527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of Recurrent Hand, Foot and Mouth Disease, China, 2008-2015.
    Huang J; Liao Q; Ooi MH; Cowling BJ; Chang Z; Wu P; Liu F; Li Y; Luo L; Yu S; Yu H; Wei S
    Emerg Infect Dis; 2018 Mar; 24(3):432-42. PubMed ID: 29460747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Nonpolio Enteroviruses in Children With Herpangina and Hand, Foot and Mouth Disease in Taiwan.
    Yang TO; Arthur Huang KY; Chen MH; Chen PC; Huang WT
    Pediatr Infect Dis J; 2019 Sep; 38(9):887-893. PubMed ID: 31033911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and managements of severe hand, foot and mouth disease caused by enterovirus A71 and coxsackievirus A16 in Shanghai, China.
    Cai K; Wang Y; Guo Z; Yu H; Li H; Zhang L; Xu S; Zhang Q
    BMC Infect Dis; 2019 Mar; 19(1):285. PubMed ID: 30917800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enterovirus spectrum from the active surveillance of hand foot and mouth disease patients under the clinical trial of inactivated Enterovirus A71 vaccine in Jiangsu, China, 2012-2013.
    Yao X; Bian LL; Lu WW; Li JX; Mao QY; Wang YP; Gao F; Wu X; Ye Q; Xu M; Li XL; Zhu FC; Liang ZL
    J Med Virol; 2015 Dec; 87(12):2009-17. PubMed ID: 26010334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular epidemiology and clinical features of hand, foot and mouth disease in northern Thailand in 2016: a prospective cohort study.
    Upala P; Apidechkul T; Suttana W; Kullawong N; Tamornpark R; Inta C
    BMC Infect Dis; 2018 Dec; 18(1):630. PubMed ID: 30522440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.